July 28, 2015
Authored and Edited by Elizabeth D. Ferrill
Trading Technologies v. Open E Cry, No. 15-1547 - Courtroom 201
This case provides another opportunity for the Federal Circuit to expand its precedent applying the four-factor test for motions to stay pending CBM review. The district court denied a stay when, as Trading Technologies argues, only a subset of the 16 asserted patents were subject to CBM and many of the defendants had not agreed to be bound by the statutory estoppel that applies to the petitioner.
Prolitec v. ScentAir Technologies, No. 15-1020 - Courtroom 402
In another appeal involving motions to amend at the PTAB, Prolitec argues that the PTAB abused its discretion by denying its motion to amend. It also claims that the PTAB failed to analyze the substitute claim as a whole, and that its regulations governing amendments are arbitrary. ScentAir counters that the amendment was taught by the prior art. The PTAB has intervened in this case.
ClearCorrect Operating v. ITC, No. 14-1527; Align Technology v. ITC, No. 14-1533 - Courtroom 201
In a closely watched case, the Federal Circuit will determine whether digital data (used to create 3D models for Invisalign® braces) constitutes an “article” within the meaning of Section 337 or whether Section 337 only applies to physical items. The ITC found ClearCorrect liable for infringement by downloading the 3D models. So the Federal Circuit will also decide whether “importation” in Section 337 gives the ITC authority over the international transmission of digital files. Many amici have filed briefs in this case.
Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
INCONTESTABLE® Blog
Netflix Prevails in Copyright Infringement Suit Regarding Tiger King
May 14, 2026
Federal Circuit IP Blog
Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay
May 14, 2026
Federal Circuit IP Blog
When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case
May 14, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.